Geoffrey Von Maltzahn

This inventor holds 104 USPTO granted patents and 65 published patent applications, plus 10 CIPO patents and 19 EPO patents, primarily in Agricultural Biotechnology (CPC class A61K45-06). Top assignees: Indigo Ag, Inc., Seres Therapeutics, Inc., Axcella Health Inc.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Geoffrey Von Maltzahn. Retrieved from https://idiyas.com/inventor/geoffrey-von-maltzahn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 104 (Patent Applications = 65)

% Patents Active = 98.1

CIPO Patents = 10 (Patent Applications = 17)

EPO Patents = 19 (Patent Applications = 66)

Average Co-Inventor Count = 7.3

ph-index = 25

Forward Citations = 2,251(Granted Patents)

Forward Citations (Not Self Cited) = 1,587(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Cambridge, MA (US) (2014)
Boston, CA (US) (2019 - 2023)
Boston, MA (US) (2014 - 2024)
Somerville, MA (US) (2016 - 2024)

Company Filing History:

Seres Therapeutics, Inc.

Kaleido Biosciences, Inc.

patents

5. 6 out of 6

Indigo Agriculture, Inc.

patents

6. 5 out of 41

Austrian Institute of Technology

patents

7. 5 out of 36

Flagship Pioneering Innovations V, Inc.

patents

8. 5 out of 8,594

Massachusetts Institute of Technology

patents

9. 4 out of 22

Dsm Nutritional Products Inc.

Children's Medical Center Corporation

patents

14. 2 out of 42

Flagship Pioneering Innovations Vi, LLC

patents

15. 1 out of 3

Flagship Pioneering Innovations Vii, LLC

patents

where one patent can have more than one assignee

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

Endophyte Compositions

Glycan Therapeutics

Machine Learning

Agronomic Traits

Bacterial Compositions

Genome Modulation

Agricultural Systems

Microorganism Propagation

Nutritional Polypeptides

Membrane Fusion

Enzyme Profiling

Satellite-Based Modeling

104 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12661366 - Oligosaccharide compositions and methods of use thereof for treating viral infections (2026-06-23),

2. 12605415 - Compositions and methods (2026-04-21),

3. 12496274 - Compositions and methods for compartment-specific cargo delivery (2025-12-16),

4. 12490744 - Methods of use of seed-origin endophyte populations (2025-12-09),

5. 12409197 - Synergistic bacterial compositions and methods of production and use thereof (2025-09-09),

6. 12398392 - Methods and compositions for modulating a genome (2025-08-26),

7. 12378578 - Fusosome compositions and uses thereof (2025-08-05),

8. 12377113 - Glycan therapeutic compositions and related methods thereof (2025-08-05),

9. 12303526 - DNA compositions and related methods (2025-05-20),

10. 12243112 - Machine learning in agricultural planting, growing, and harvesting contexts (2025-03-04),

11. 12090168 - Glucose glycans for treating urea cycle disorders (2024-09-17),

12. 12083151 - Synergistic bacterial compositions and methods of production and use thereof (2024-09-10),

13. 12031129 - Methods and compositions for modulating a genome (2024-07-09),

14. 11918612 - Synergistic bacterial compositions and methods of production and use thereof (2024-03-05),

15. 11915329 - Interaction management in an online agricultural system (2024-02-27),

Title: The Innovative Journey of Geoffrey von MALTZAHN

Introduction:

Geoffrey von MALTZAHN is a renowned inventor based in Boston, MA (US) known for his groundbreaking contributions to the field of biotechnology and healthcare.

Latest Patents:

Geoffrey von MALTZAHN holds several patents in the areas of drug delivery systems, nanotechnology, and biomedical engineering, showcasing his commitment to advancing medical technologies.

Career Highlights:

With a background in bioengineering and a Ph.D. from MIT, Geoffrey von MALTZAHN has established himself as a leading figure in the intersection of science and innovation. His career highlights include the development of novel cancer therapies and diagnostic tools that have the potential to revolutionize the healthcare industry.

Collaborations:

Geoffrey von MALTZAHN has collaborated with top research institutions, pharmaceutical companies, and academic experts to further his research and bring his inventions to market. His collaborative spirit has led to the successful translation of cutting-edge technologies from the lab to real-world applications.

Conclusion:

In conclusion, Geoffrey von MALTZAHN's relentless pursuit of innovation and his passion for improving human health have solidified his reputation as a visionary inventor in the field of biotechnology. His work continues to inspire the next generation of inventors and researchers to push the boundaries of what is possible in science and technology.

Profile summary based on public USPTO records.